When starting warfarin in atrial fibrillation, you need to establish the patient’s baseline coagulation status and organ function because warfarin’s effect depends on hepatic metabolism and vitamin K–dependent clotting. A CBC checks for thrombocytopenia or existing anemia that could raise bleeding risk. Kidney and liver function are important because warfarin is processed mainly by the liver, and liver disease can increase bleeding risk and alter metabolism; kidney function helps gauge overall health and potential medication interactions. A baseline INR is essential to know where the patient stands before therapy and to guide future dose adjustments and monitoring. Also, assessing potential drug interactions and overall bleeding risk informs safe initiation and management of therapy. Lipid panel, electrolyte panel, and thyroid function aren’t required specifically to start warfarin, though they may be relevant for broader AF care.

Hepatocellular carcinoma arises from hepatocytes, the liver’s main parenchymal cells responsible for metabolism and detoxification. Chronic liver injury from hepatitis viruses, alcohol, or fatty liver leads to genetic mutations in hepatocytes and their clonal expansion into cancer. Other liver cell types have different tumor origins: cholangiocytes line the bile ducts and give rise to cholangiocarcinoma; endothelial cells line the blood vessels and can form other vascular tumors; hepatic stellate cells are involved in fibrosis and are not the source of hepatocellular carcinoma. Thus, the cancer originates from hepatocytes.

When adherence to antiseizure medication is the main issue, the most important step is to assess and address barriers to taking the medicine and to optimize the regimen for easier, safer use while reinforcing safety plans. Work with the family to identify why doses are missed—cost, access, complicated schedules, side effects, or forgetfulness—and then simplify the plan: consider once-daily or longer-acting formulations if available, use reminders or pill organizers, and provide clear, practical instructions and education for both the child and caregivers. Pair this with safety planning so the patient has a clear plan for seizures and knows what to do at home or at school, including any rescue medications if prescribed. Changing to a different drug class without tackling adherence, pursuing immediate surgical evaluation, or doing nothing and trial-and-error dosing all fail to address the root issue and can lead to continued seizures and increased risk.

Starting warfarin requires knowing how your blood clots now and whether your organs that influence drug handling are functioning properly. The liver synthesizes the vitamin K–dependent clotting factors that warfarin ultimately reduces, so checking liver function helps anticipate how strongly the INR may rise and how risky bleeding could be. A baseline INR is important because you’ll be using INR to guide dosing once therapy begins, so knowing the current coagulation status provides a reference point for future monitoring. A complete blood count is needed to assess platelets and baseline anemia, both of which raise bleeding risk if you anticoagulate. Kidney function is checked because renal disease is common in patients with atrial fibrillation and can affect overall management and bleeding risk, even though warfarin itself is primarily metabolized by the liver. Lipid panel, potassium, and thyroid function aren’t routinely required solely to start warfarin, as they don’t directly determine initial dosing or immediate bleeding risk in the way the above tests do.